Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SAP-021-T1
- Development stage
- Unknown
- Lead developer
- Avata Biosciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
SAP-021-T1 is an investigational, novel oral solid-dose (capsule) formulation of synthetic cannabidiol (CBD) developed by Avata Biosciences (formerly Sapient Therapeutics). It is one of two candidate formulations (alongside SAP-021-T2) designed to improve the pharmacokinetic profile and bioavailability of cannabidiol compared to existing oil-based solutions like Epidiolex. The drug is being developed via the FDA's 505(b)(2) regulatory pathway, leveraging the established safety and efficacy data of cannabidiol for the treatment of epilepsy-related seizure disorders, including Dravet syndrome and other treatment-resistant epilepsies. SAP-021-T1 has been evaluated in Phase 1 clinical trials to assess its relative bioavailability and the impact of food on its absorption in healthy volunteers.
- Other names
- synthetic cannabidiol capsule
02
Targets
CNR1 (Cannabinoid receptor 1)ENT1 (Solute carrier family 29 member 1)GPR55 (G protein-coupled receptor 55)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on SAP-021-T1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SAP-021-T1.